"10.1371_journal.pone.0033351","plos one","2012-03-30T00:00:00Z","Anke Zschüttig; Kurt Zimmermann; Jochen Blom; Alexander Goesmann; Christoph Pöhlmann; Florian Gunzer","Institute of Medical Microbiology and Hygiene, TU Dresden, Dresden, Germany; SymbioPharm GmbH, Herborn-Hörbach, Germany; CeBiTec, University of Bielefeld, Bielefeld, Germany; Abteilung für Labormedizin, Robert Bosch Krankenhaus, Stuttgart, Germany","Conceived and designed the experiments: FG AZ. Performed the experiments: AZ. Analyzed the data: AZ KZ CP FG. Contributed reagents/materials/analysis tools: KZ JB AG CP. Wrote the paper: AZ FG.","The authors have read the journals policy and they have the following conflicts. KZ is an employee of SymbioPharm. FG, AZ and KZ have submitted a patent application disclosing the discovery of Bacterially formed microcin S, a new antimicrobial peptide, effective against pathogenic microorganisms (EP 11177451). This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2012","03","Anke Zschüttig","AZ",6,TRUE,2,1,4,2,TRUE,TRUE,FALSE,0,NA,FALSE
